Skip to content
Open access

Preoperative OCT biomarkers and surgical outcomes after vitrectomy with epiretinal membrane and internal limiting membrane peeling for refractory diabetic macular edema: a retrospective cohort study

Sep 2026 · BMC Ophthalmology · Vol 26 · 0 citations · 35 references
Medicine

TL;DR

PPV with ERM and ILM peeling was associated with significant anatomical and functional improvement in selected eyes with refractory DME and preoperative OCT biomarkers showed the most consistent prognostic association with postoperative visual outcome.

Abstract

Vitrectomy with epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling may provide anatomical and functional benefit in selected eyes with refractory diabetic macular edema, but predictors of postoperative outcome remain incompletely defined. This study aimed to evaluate the anatomical and functional outcomes of pars plana vitrectomy (PPV) combined with ERM and ILM peeling in eyes with diabetic macular edema (DME) and to investigate the prognostic value of preoperative OCT biomarkers for postoperative outcomes. Thirty eyes of 30 patients with DME refractory to repeated intravitreal anti-VEGF and/or corticosteroid therapy underwent 25-gauge PPV with ERM and ILM peeling. Best-corrected visual acuity (BCVA), central subfield thickness (CST), postoperative treatment requirement, and preoperative OCT biomarkers were evaluated. Associations between baseline OCT biomarkers and 12-month anatomical and functional outcomes were assessed using unadjusted analyses and multivariable regression models. Mean BCVA improved from 1.08 ± 0.52 logMAR at baseline to 0.65 ± 0.42 logMAR at 12 months (P < 0.001), while mean CST decreased from 533.80 ± 100.31 μm to 261.23 ± 34.31 μm (P < 0.001). Baseline DRIL was independently associated with worse 12-month BCVA (β = 0.399, 95% CI 0.035–0.762; P = 0.032). Eyes with intact EZ showed greater numerical visual improvement than those with EZ disruption, although the difference was not statistically significant (P = 0.093). Absence of baseline HRF was associated with greater CST reduction in the unadjusted analysis (P < 0.001), but HRF was not independently associated with 12-month CST (P = 0.309). During postoperative follow-up, 22 eyes (73.3%) required no additional intravitreal treatment. PPV with ERM and ILM peeling was associated with significant anatomical and functional improvement in selected eyes with refractory DME. Among the preoperative OCT biomarkers evaluated, DRIL showed the most consistent prognostic association with postoperative visual outcome. Preoperative assessment of retinal microstructure may provide complementary information for visual prognostication and patient counseling.

Read PDF

Similar papers

Open access Sep 2026

Visual and Anatomical Outcomes of Vitrectomy with ERM and ILM Peeling in Idiopathic and Secondary ERM

Background/Objectives: To evaluate the visual and anatomical outcomes of pars plana vitrectomy (PPV) with epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling and to assess the impact of etiological differences on postoperative outcomes. Methods: This retrospective study included 57 eyes of 51 patient...

İsa Yuvacı, Kübra Özata Gündoğdu, Eda Gümrükçüoğlu · 0 citations
Open access Aug 2026

Anatomical and functional outcomes and prognostic factors after idiopathic full-thickness macular hole surgery: a single-center retrospective cohort study

Baseline visual acuity and MLD may be clinically relevant markers of postoperative outcome, whereas the apparent unadjusted visual benefit of temporal inverted ILM flap surgery should be interpreted cautiously.

A. Filik, Mısra Şirvanlıoğlu, Gaye Güner et al. · 0 citations
Open access Sep 2026

Treatment-Emergent Epiretinal Membrane in Diabetic Macular Edema: A Real-World OCT-Based Comparative Pharmacotherapy Study Across Intravitreal Agents—The TRIDENT-DME Study

Purpose: To evaluate the incidence, predictors, and clinical impact of treatment-emergent epiretinal membrane (ERM) in diabetic macular edema (DME) treated with dexamethasone implant, aflibercept, ranibizumab, bevacizumab, or faricimab. Methods: In this multicenter, retrospective, nonrandomized study, 501 eyes with cen...

Debdulal Chakraborty, T. Sinha, R. Biswas et al. · 0 citations
Open access Oct 2026

Pre-Operative and Surgical Factors Influencing Outcomes of Vitrectomy for Myopic Foveoschisis.

BACKGROUND To evaluate the surgical outcomes of pars plana vitrectomy (PPV) for myopic foveoschisis (MF), focusing on the impact of baseline traction and atrophy severity, internal limiting membrane (ILM) peeling techniques and tamponade selection on anatomical and functional recovery. METHODS This retrospective cons...

R. Wan, Shu Y. Lee, D. Ting et al. · 0 citations
Review Sep 2026

Dexamethasone Sustained-Release Implant Enhances Early Visual Recovery Following Minimally Invasive Vitrectomy for Idiopathic Epiretinal Membrane: A Retrospective Cohort Study.

INTRODUCTION/OBJECTIVE Idiopathic epiretinal membrane (iERM) is a common cause of visual distortion and central acuity loss, driven by fibrocellular traction on the macula. Although vitrectomy with membrane peeling effectively releases mechanical traction, surgical trauma disrupts the inner blood-retinal barrier, leadi...

Jing Yuan, Bi-Yue Tu, Zhen Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.